How long does it take for Gemtesa (vibegron) to leave the body?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gemtesa (Vibegron) Elimination Time

Gemtesa (vibegron) takes approximately 5-6 days to be substantially eliminated from the body, based on its effective half-life of 30.8 hours, meaning that after stopping the medication, over 95% will be cleared within this timeframe. 1

Pharmacokinetic Profile

Vibegron has an effective half-life of 30.8 hours across all populations. 1 Using standard pharmacokinetic principles, a drug is considered essentially eliminated after 5 half-lives (when approximately 97% has been cleared from the body):

  • After 1 half-life (31 hours): ~50% remains 1
  • After 2 half-lives (62 hours): ~25% remains 1
  • After 3 half-lives (93 hours): ~12.5% remains 1
  • After 4 half-lives (124 hours): ~6% remains 1
  • After 5 half-lives (154 hours/6.4 days): ~3% remains 1

Excretion Pathways

The drug is eliminated through both renal and fecal routes: 1

  • 59% recovered in feces (54% as unchanged drug) 1
  • 20% recovered in urine (19% as unchanged drug) 1
  • Metabolism plays only a minor role in elimination, with CYP3A4 being the predominant enzyme responsible 1

Special Population Considerations

No clinically significant differences in vibegron elimination occur based on: 1

  • Age (18-93 years) 1
  • Sex 1
  • Mild to moderate renal impairment (eGFR 30-89 mL/min/1.73 m²) 1
  • Severe renal impairment (eGFR 15-29 mL/min/1.73 m²) 1
  • Moderate hepatic impairment (Child-Pugh B) 1

Important caveat: The effect of end-stage renal disease requiring hemodialysis (eGFR <15 mL/min/1.73 m²) or severe hepatic impairment (Child-Pugh C) on vibegron elimination was not studied, so elimination may be prolonged in these populations. 1

Clinical Implications

Steady-state concentrations are achieved within 7 days of once-daily dosing, with a mean accumulation ratio of 1.7 for peak concentration and 2.4 for overall exposure. 1 This means the drug accumulates moderately with repeated dosing, which is consistent with its 30.8-hour half-life. 1

For practical purposes, patients can expect the medication to be largely out of their system within approximately one week after discontinuation, though trace amounts may persist slightly longer. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.